Antiviral lectins from red and blue-green algae show potent in vitro and in vivo activity against hepatitis C virus.

Hepatitis C virus (HCV) infection is a significant public health problem with over 170,000,000 chronic carriers and infection rates increasing worldwide. Chronic HCV infection is one of the leading causes of hepatocellular carcinoma which was estimated to result in ∼10,000 deaths in the United State...

Full description

Saved in:

Bibliographic Details
Main Authors:	Yutaka Takebe, Carrie J Saucedo, Garry Lund, Rie Uenishi, Saiki Hase, Takayo Tsuchiura, Norman Kneteman, Koreen Ramessar, D Lorne J Tyrrell, Masayuki Shirakura, Takaji Wakita, James B McMahon, Barry R O'Keefe
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2013-01-01
Series:	PLoS ONE
Online Access:	https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0064449&type=printable
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!

Antiviral lectins from red and blue-green algae show potent in vitro and in vivo activity against hepatitis C virus.

Similar Items